Table 2.
Causative pathogens identified preoperatively and their proportions.
Pathogen | Bioactive glass | Autologous bone graft |
---|---|---|
Total number of patients with known pathogens | ||
Total number of positive microbiology findings | 79 (100 %) | 39 (100 %) |
Staph. aureus | 22 (28 %) | 8 (21 %) |
COST | 22 (28 %) | 11 (28 %) |
MRSA | 2 (2 %) | 3 (7 %) |
Streptococcus | 6 (8 %) | 0 (0 %) |
Enterococcus | 5 (6 %) | 1 (3 %) |
Enterobacter | 3 (4 %) | 2 (5 %) |
Proteus | 1 (1 %) | 1 (3 %) |
Serratia | 3 (4 %) | 1 (3 %) |
Pseudomonas | 6 (8 %) | 0 (0 %) |
E. coli | 3 (4 %) | 5 (12 %) |
Others | 6 (8 %) | 7 (18 %) |
COST: coagulase-negative Staphylococci; MRSA: methicillin-resistant Staph. aureus; E. coli: Escherichia coli. Multiple nominations per patient possible. Percentages are given in relation to all positive microbiology findings, not in relation to the number of patients; therefore, differences are possible compared to Table 1 (percentages in relation to the number of analyzed patients).